ReviewInhalation toxicology
Modeling environmental inhalant exposure in rheumatoid arthritis.
Review in Inhalation toxicology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
The mucosal origins hypothesis posits that environmental inhalant exposures, including cigarette smoke (CS) and crystalline silica (c-silica), trigger immune responses in the lung mucosa, an extra-articular site, which precede initiating events of rheumatoid arthritis (RA) pathogenesis in distant joints. Epidemiological data strongly associates these exposures with RA risk, especially in genetically susceptible individuals carrying HLA-DRB1 alleles, and with the production of autoantibodies such as anti-citrullinated peptide antibodies (ACPA) and rheumatoid factor (RF). However, establishing causality remains challenging due to unsynchronized exposure and disease onset and the lack of suitable animal models to study early disease events. This review synthesizes evidence linking inhalant exposures to RA, focusing on CS and c-silica, and evaluates experimental animal models used to investigate disease initiation and progression in the context of inhalant exposures. While models like collagen-induced arthritis (CIA) replicate joint pathology, they often fail to capture the lung-joint axis and gene-environment interactions critical for RA onset. We highlight the need for refined models with genetic susceptibility to subclinical autoimmunity to better mimic human RA, emphasizing the importance of standardized exposure protocols to address variability in outcomes. These advancements are crucial for elucidating mechanisms of inhalant exposure-induced RA and developing preventive strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.